Patau syndrome is a rare and severe genetic condition resulting from the presence of an extra copy of chromosome 13. The syndrome is named in honor of Klaus Patau, a German-American geneticist who initially identified the genetic basis of the disease in 1960. According to a clinical case discussion published in the scientific journal of the Lithuanian University of Health Sciences (LSMU), the prevalence of Patau syndrome is estimated at 1 in 5,000 live births, although the majority of fetuses with T13 are lost in utero.
The article detailed the case of six children whose parents were at risk. Doctors in Kaunas noted that diagnosis of Patau syndrome is often suspected during routine ultrasound examinations, where characteristic anomalies can be observed. Further diagnostic confirmation may involve combined testing or Non-Invasive Prenatal Testing (NIPT).
Treatment for Patau syndrome is typically supportive, focusing on managing symptoms rather than a cure. The complex nature of the disease leads to significant developmental and organ abnormalities in affected individuals. The rarity and severity of Patau syndrome underscore the importance of early prenatal screening methods for detecting chromosomal abnormalities.
Topics: #patau #syndrome #disease
